Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$633M |
| 2 |
Willis Towers Watson
WTW
|
+$528M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$525M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
| 5 |
AGN
Allergan plc
AGN
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.17B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$352M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$339M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.73% |
| 2 | Healthcare | 5.73% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 4.7% |
| 5 | Communication Services | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
CALL
TG Therapeutics
TGTX
$7.07B
| $707K | ﹤0.01% |
71,900
-18,300
| -20% | -$231K |
|
3477
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.93B
| $706K | ﹤0.01% |
34,589
-7,317
| -17% | -$231K |
|
3478
PUT
Axalta
AXTA
$7.76B
| $705K | ﹤0.01% |
40,800
-41,000
| -50% | -$1.05M |
|
3479
Essential Properties Realty Trust
EPRT
$6.74B
| $705K | ﹤0.01% |
54,013
-28,673
| -35% | -$664K |
|
3480
PUT
NovaGold Resources
NG
$2.61B
| $705K | ﹤0.01% |
96,700
-47,400
| -33% | -$405K |
|
|
ECHO
3481
EchoStar
ECHO
$24.8B
| $704K | ﹤0.01% |
22,031
+9,409
| +75% | +$352K |
|
|
DRNA
3482
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $704K | ﹤0.01% |
38,288
+22,311
| +140% | +$434K |
|
|
ENDP
3483
DELISTED
Endo International plc
ENDP
| $701K | ﹤0.01% |
189,432
-136,992
| -42% | -$694K |
|
3484
Axsome Therapeutics
AXSM
$10.9B
| $700K | ﹤0.01% |
11,894
+3,547
| +42% | +$289K |
|
3485
PUT
Ionis Pharmaceuticals
IONS
$9.06B
| $700K | ﹤0.01% |
14,800
-22,500
| -60% | -$1.25M |
|
3486
CALL
AMC Entertainment Holdings
AMC
$2.54B
| $699K | ﹤0.01% |
22,130
-27,030
| -55% | -$1.56M |
|
3487
State Street SPDR S&P Pharmaceuticals ETF
XPH
$491M
| $699K | ﹤0.01% |
19,371
-1,640
| -8% | -$69.9K |
|
|
PLAN
3488
PUT
DELISTED
Anaplan, Inc.
PLAN
| $699K | ﹤0.01% |
23,100
-3,100
| -12% | -$155K |
|
3489
CALL
Winnebago Industries
WGO
$885M
| $698K | ﹤0.01% |
25,100
+5,000
| +25% | +$241K |
|
3490
AMERISAFE
AMSF
$564M
| $697K | ﹤0.01% |
10,816
-17,073
| -61% | -$1.12M |
|
3491
CALL
GoPro
GPRO
$131M
| $697K | ﹤0.01% |
265,900
-176,000
| -40% | -$654K |
|
|
SYKE
3492
DELISTED
SYKES Enterprises Inc
SYKE
| $697K | ﹤0.01% |
25,680
-21,751
| -46% | -$701K |
|
3493
Employers Holdings
EIG
$910M
| $695K | ﹤0.01% |
17,164
-24,123
| -58% | -$987K |
|
|
MFA
3494
MFA Financial
MFA
$931M
| $695K | ﹤0.01% |
112,025
+12,028
| +12% | +$320K |
|
|
SIVB
3495
CALL
DELISTED
SVB Financial Group
SIVB
| $695K | ﹤0.01% |
4,600
+3,400
| +283% | +$748K |
|
3496
National Fuel Gas
NFG
$7.87B
| $693K | ﹤0.01% |
18,617
-1,398
| -7% | -$57.3K |
|
3497
Reynolds Consumer Products
REYN
$5.32B
| $692K | ﹤0.01% |
+23,700
| New | +$683K |
|
3498
CALL
StoneCo
STNE
$2.76B
| $692K | ﹤0.01% |
31,800
-4,600
| -13% | -$175K |
|
3499
CALL
Ligand Pharmaceuticals
LGND
$5.85B
| $691K | ﹤0.01% |
15,229
-10,579
| -41% | -$600K |
|
3500
Macerich
MAC
$7.34B
| $691K | ﹤0.01% |
122,654
-20,209
| -14% | -$402K |
|
Similar funds
Citigroup's Q1 2020 Portfolio in Review
As of Q1 2020, Citigroup held 8,003 positions worth $111B, down 20% from $138B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup's Q1 2020 filing shows 244 new, 3,316 increased, 3,513 reduced and 342 closed positions. Its largest new stake was Direxion Flight to Safety Strategy ETF: 100,000 shares worth $5.01M. The largest sale was Invesco QQQ Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.7% a quarter earlier, followed by Healthcare and Financials.
- Citigroup's largest Q1 2020 buy was Direxion Flight to Safety Strategy ETF: 100,000 shares worth $5.01M.
- Citigroup added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2020, an estimated $633M increase.
- Citigroup's biggest Q1 2020 reduction was Invesco QQQ Trust, cutting an estimated $1.17B.
- Citigroup fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $327M.
- Citigroup's ten largest holdings make up 24% of its $111B portfolio in Q1 2020.
- Citigroup opened 244 new positions and closed 342 in Q1 2020.
- Citigroup's portfolio value fell 20% quarter-over-quarter to $111B.
Based on Citigroup's 13F filing for Q1 2020, filed 12 May 2020.